RACHEL BARRY, MD
Otolaryngology Physician in LAFAYETTE, Louisiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
RACHEL BARRY, MD reported a CMS MIPS final score of 77.3806/100 — below the 83.1 national average — and filed 347 Medicare Part D claims in 2023.
- 77.3806/100
- MIPS score · -6 vs avg
- 347
- Part D claims, 2023
- 95%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
RACHEL BARRY, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
77 24th percentile higher than 24% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
RACHEL BARRY, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about RACHEL BARRY, MD?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Louisiana
How Otolaryngology Physician compares to other specialties among Louisiana providers
Otolaryngology Physician share within Louisiana
Otolaryngology Physician is one of the more visible NUCC categories in Louisiana
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
RACHEL BARRY, MD's 2023 MIPS final score plotted against the Otolaryngology Physician national average
- MIPS Final Score
- 77.3806/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Otolaryngology Physician) — 77.3806/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Otolaryngology Physician US NPIs
77.3806/100 MIPS final score — 5.7 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Otolaryngology Physician. Quality dim: 56.3438. Cost dim: 68.2582.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
RACHEL BARRY, MD appears in the CMS NPPES registry as a Otolaryngology Physician provider holding MD credentials at 4212 W CONGRESS ST STE 1500, LAFAYETTE, LA, 70506, with a listed phone of (337) 981-6464. NPI 1184966962 was issued on 03/20/2013. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BARRY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 347 prescription claims written by this provider, covering 127 Medicare beneficiaries and totaling roughly $6K in drug spend, split 5% brand-name and 95% generic by claim count, with an opioid prescribing rate of 3.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 77.3806/100 for the 2023 performance year (Quality 56.3438, Cost 68.2582), compared with the national average of 83.1.
Otolaryngology Physician is a mid-sized specialty nationwide, with 10,895 enrolled providers across 54 states and an average of 509 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1184966962 |
|---|---|
| Specialty | Otolaryngology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 03/20/2013 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm RACHEL BARRY, MD's current license status, disciplinary history, and board certifications with the Louisiana State Board of Medical Examiners in Louisiana before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where RACHEL BARRY, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Generic-heavy
5% brand-name claims vs 95% generic, on 347 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 418
- Total Day Supply
- 8,829
- Brand vs Generic
- 5% brand / 95% generic
- Brand Drug Cost
- $633
- Generic Drug Cost
- $6K
- Opioid Claims
- 11 (3.2% rate)
- Antibiotic Claims
- 68
Patient Demographics
- Average Patient Age
- 72.5 years
- Avg HCC Risk Score
- 1.19
- Gender Split
- 61% female / 39% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What RACHEL BARRY, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Omeprazole
Omeprazole
45 claims
- Azelastine Hcl
Azelastine Hcl
30 claims
- Ofloxacin
Ofloxacin
28 claims
- Amoxicillin-Clavul…
Amoxicillin-Clavulanate Potass
25 claims
- Fluticasone Propio…
Fluticasone Propionate
21 claims
- Prednisone
Prednisone
19 claims
- Ipratropium Bromide 17
Ipratropium Bromide
17 claims
- Levocetirizine Dih… 14
Levocetirizine Dihydrochloride
14 claims
| Drug | Claims |
|---|---|
| Omeprazole | 45 |
| Azelastine Hcl | 30 |
| Ofloxacin | 28 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 25 |
| Fluticasone Propionate | 21 |
| Prednisone | 19 |
| Ipratropium Bromide | 17 |
| Levocetirizine Dihydrochloride | 14 |
| Mupirocin | 13 |
| Amoxicillin | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Otolaryngology Physician Overview
How RACHEL BARRY, MD fits within the Otolaryngology Physician landscape nationally.
RACHEL BARRY, MD's 347 claims are below the specialty average of 509.
Nearby Otolaryngology Physician Providers in Louisiana
Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as BARRY.
Compare Otolaryngology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Louisiana
Frequently Asked Questions
What is RACHEL BARRY, MD's specialty? ▼
How much does RACHEL BARRY, MD prescribe under Medicare Part D? ▼
What is RACHEL BARRY, MD's Medicare quality score? ▼
Where is RACHEL BARRY, MD located? ▼
What is RACHEL BARRY, MD's NPI number? ▼
Does RACHEL BARRY, MD prescribe more brand-name or generic drugs? ▼
Does RACHEL BARRY, MD prescribe opioids? ▼
How many Otolaryngology Physician providers are there in the US? ▼
What drugs does RACHEL BARRY, MD prescribe most often? ▼
Does RACHEL BARRY, MD accept Medicare? ▼
How can I verify RACHEL BARRY, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology